Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate Cbp-201 In Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Posted Date: Nov 19, 2021
- Investigator: Ahmad Sedaghat
- Type of Study: Drug
To evaluate the efficacy of CBP-201 on a background of mometasone furoate nasal spray (MFNS) in reducing endoscopic nasal polyp score (NPS) and nasal congestion/obstruction score (NCS) severity in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) whose disease remains inadequately controlled despite daily treatment with intranasal corticosteroid (INCS) therapy in comparison to placebo.
Patients Who Are Diagnosed With Chronic Rhinosinusitis With Bilateral Polyps Despite Treatment With Systemic Corticosteroid Within The Past 2 Years
Chronic Rhinosinusitis, Nasal Polyps
For More Information: